Navigation Links
BioNeutral Gains Initial Market Acceptance
Date:2/25/2013

pressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA has approved and registered the Company's data and findings specific to Ygiene-206. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene® and are available for sale in the United States.


'/>"/>
SOURCE BioNeutral Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioNeutral Group Receives Positive Testing Results From A Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores
2. BioNeutral Group Appoints Mr. Mark Lowenthal as Chief Executive and President
3. BioNeutral Group Expands The Testing Of Its Ygiene Sterilant Against Anthrax Spores
4. BioNeutral Group Appoints A New Member to the Board of Directors
5. BioNeutral Group Receives $400,000 in Equity Financing
6. A possible answer for protection against chemical/biological agents, fuel leaks, and coffee stains
7. Two University of Colorado Cancer Center Studies Show that Silibinin, Found in Milk Thistle, Protects Against UV-Induced Skin Cancer
8. Tracking the Battle Against Breast Cancer With New Market Research
9. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
10. Doctors Without Borders and DNDi: Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases
11. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NIAGARA FALLS, N.Y., Jan. 15, 2014   Niagara ... has been selected by Buffalo BioBlower Technologies LLC ("B3") ... its SBIR Phase 2 award from the Army Corps ... purification system that kills all biological contaminants and destroys ...
(Date:1/15/2014)... 15, 2014 This webinar will focus ... clinical safety assessment in biosimilars. , Regulatory frameworks are ... drug development, however the complex nature of biopharmaceuticals makes ... and efficacy extremely challenging. Based on the specific aspects ...
(Date:1/15/2014)... January 15, 2014 DTS Language Services, ... Online Web Portal for Life Science organizations who need document ... the subject matter of their documents in advance with a ... reduce time-to-delivery of translations, often a critical factor in clinical ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: ... 1360 Almshouse Road, Warrington, Pa. , Details: The ... to finding a cure for hepatitis B and improving the ... annual Crystal Ball on Friday, April 11 at Warrington Country ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... PharmAthene, Inc. (NYSE Amex: PIP ) ... the development of its second generation anthrax vaccine, SparVax™. ... 100 liter scale and demonstrating 36 month stability, the ... 1,500 liter engineering production run for SparVax™.  As a ...
... Sept. 9, 2011 Palatin Technologies, Inc. (NYSE Amex: ... the Rodman & Renshaw Annual Global Investment Conference on Tuesday, ... will be held at The Waldorf Astoria in New York, ... Executive Officer of Palatin Technologies, will provide an update on ...
... England, September 9, 2011 PharmaVentures ... to announce that they have been engaged by ... a buyer for an established full service CMC ... Pleasanton, California. The engagement will utilise PharmaVentures, asset ...
Cached Biology Technology:PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program 2PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program 3PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program 4
(Date:7/9/2014)... of the puzzle behind nature,s ability to split ... advance the development of artificial photosynthesis for clean, ... an international collaboration of scientists led by researchers ... and the SLAC National Accelerator Laboratory. , ... the world,s most powerful x-ray laser, the researchers ...
(Date:7/9/2014)... children with traumatic injuries have identified an immune ... develop a hospital-acquired infection. The study, led by ... in June in the journal Shock , ... lead to the clinical implementation of quick-turnaround immune ... immune system damage following critical illness or injury ...
(Date:7/9/2014)... co-authored by a University of Guelph scientist that ... shows long-term exposure to a neonicotinoid pesticide hampers ... research by Nigel Raine, a professor in Guelph,s ... Imperial College London was published July 9 in ... . , The study shows how long-term pesticide ...
Breaking Biology News(10 mins):Postcards from the photosynthetic edge 2Postcards from the photosynthetic edge 3Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3Bee foraging chronically impaired by pesticide exposure: Study 2
... and vegetables that are rich in nitrates protect the ... nitrates into nitrites by the bacteria in the oral ... in the stomach. The Swedish researcher Joel Petersson has ... can be harmful for the stomach. "Nitrates in ...
... behind mad cow disease and its human variation, Creutzfeldt-Jakob ... findings from Gerald Zamponi and colleagues, normally functioning prions ... appear in the May 5th issue of the Journal ... when the prion protein adopts an abnormal conformation. This ...
... in Support of "New Employee,Verification Act", ALEXANDRIA, ... to human resource management today led a coalition ... "New Employee,Verification Act." In testimony today before the ... Meisinger, President and CEO of SHRM,urged legislators to ...
Cached Biology News:Nitrates in vegetables protect against gastric ulcers 2Nitrates in vegetables protect against gastric ulcers 3Nitrates in vegetables protect against gastric ulcers 4Nitrates in vegetables protect against gastric ulcers 5SHRM CEO Testifies Before House Subcommittee on Social Security 2SHRM CEO Testifies Before House Subcommittee on Social Security 3
...
...
... Novagen's frozen Sf9 Insect Cells are derived from ... pretested for optimal growth, use in transfections, plaque ... are frozen in a protocol that optimizes recovery ... for growth in serum-free BacVector Insect Cell Medium ...
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
Biology Products: